Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790382 | Urologic Oncology: Seminars and Original Investigations | 2017 | 10 Pages |
Abstract
These results suggest that cell cycle regulatory gene polymorphisms rs2273535 and rs9904341 may contribute to UTUC susceptibility; gene polymorphism rs1801270 may contribute to prognosis of UTUC and prognosis of UC. The p53 polymorphisms may not correlate with UTUC susceptibility and prognosis of UTUC or UC. Further well-designed, large-scale studies are needed to clarify these findings.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ying-Chu Ph.D., Tzyh-Chyuan Ph.D., Yu-Chieh M.D., Shu-Pin M.D., Ph.D., Wen-Jeng M.D., Ph.D., Chung-Hsin M.D., Ph.D., Yeong-Shiau M.D., Ph.D., Shiu-Dong M.D., Ph.D, Chao-Yuan M.D., Ph.D.,